Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Arch Phys Med Rehabil. 2018 Feb 1;99(7):1333–1341. doi: 10.1016/j.apmr.2017.12.033

Differences in Physical Performance Measures among Patients with Unilateral Lower-Limb Amputations Classified as Functional Level K3 versus K4

Jaclyn Megan Sions 1, Emma Haldane Beisheim 1, Tara Jo Manal 1, Sarah Carolyn Smith 1, John Robert Horne 2, Frank Bernard Sarlo 3
PMCID: PMC6019138  NIHMSID: NIHMS939457  PMID: 29410114

Abstract

Objective

To determine if differences in physical function, assessed via self-report questionnaires and physical performance tests, exist between individuals with lower-limb loss using a prosthetic device classified as a K3 versus a K4 functional level.

Design

Cross-sectional study.

Setting

University of Delaware Physical Therapy Amputee Clinic.

Participants

Participants (n=55) were included if they were aged ≥18 years with a unilateral transfemoral or transtibial amputation, classified as K3 or K4 functional level, completed all relevant outcome measures, and currently were using a prosthesis.

Interventions

Not applicable.

Main Outcome Measures

Locomotor Capabilities Index (LCI), Prosthetic Evaluation Questionnaire-Mobility Section (PEQ-MS), Timed Up and Go (TUG), 10-Meter Walk Test (10MWT), Amputee Mobility Predictor (AMPPRO), and 6 Minute Walk Test (6MWT). K-level was determined by group consensus based on a standardized clinical evaluation.

Results

After controlling for covariates, patients classified as K3 had slower TUG times (p=.002) and self-selected and fast gait speeds (p<.001), lower AMPPRO scores (p<.001), and walked shorter distances during the 6MWT (p=.003) when compared to patients classified as K4. No significant between-group differences for the LCI or PEQ-MS were found.

Conclusions

Clinicians involved in prosthetic prescription may consider including the TUG, 10MWT, AMPPRO, and 6MWT during their clinical evaluations to help differentiate between individuals of higher functional mobility. The LCI and PEQ-MS may be less useful in classifying individuals as K3 versus K4 due to a ceiling effect.

Keywords: outcome measure, amputation, prosthetics


In the United States, lower-limb amputation rates are increasing.1 For example, disease-associated, major limb amputations increased from 5.1 in 100 persons with lower extremity ulcers in 2005 to 13.5 in 100 persons in 2013.2 Increasing demand for prosthetic device coverage is met with heightened third-party payer scrutiny.3,4 Appropriate prosthetic prescription and reimbursement is important to maximize outcomes following amputation, as prosthesis use is associated with higher levels of function, independence, and perceived quality-of-life.4,5 For individuals with functional mobility needs exceeding basic ambulation, it may be expected that advanced prosthetic technologies would be reimbursable, however, the completeness and strength of the documentation of medical necessity is critical.3

Prosthetic coverage is commonly denied for lack of (a) objective documentation of functional capabilities; 6,7 (b) consideration of factors that impact prosthetic use and ambulatory potential;6,8,9 and/or (c) prosthetic recommendations matching the patient’s clinical presentation.7 Medicare Functional Classification Levels, or K-levels, are used to describe functional mobility and prescribe prosthetic componentry for individuals with lower-limb amputations.6,10 K-level assignments range from K0 (lowest) to K4 (highest) and describe mobility potential when using a prosthesis.6 At present, there is no gold standard for establishing K-levels; assignment may be largely based on a clinician’s subjective perception.11

Of prosthetist practitioners, 75% support outcome measure use to enhance K-level assignment objectivity,11 but studies have reported only 38–67% of practitioners routinely use outcome measures.11,12 While discrepancies exist between practitioner support for and clinical use of outcome measures, recent healthcare shifts, such as requirements for clear justification of functional level classification for Medicare recipients (i.e. G-codes), mandate use.13 Such requirements set the stage for decreased variability in functional level classification, which may enhance objective documentation for (a) prosthetic prescription and (b) longitudinal monitoring of patient progress.7

Outcome measures used to document functional mobility fall into two categories, i.e. self-report, which captures a patient’s perceived functional capacity, and performance-based, which captures demonstrated physical capacity.14 Several measures in both categories have been validated in individuals with lower-limb amputation,3,6,7,15–20 and some have been assessed for their ability to distinguish between K-levels.3,6,15,21 For example, the Amputee Mobility Predictor (AMPPRO) and the 6 Minute Walk Test (6MWT) have been shown to correlate to K-level assignment;3,6,21 however, overlapping scores exist between K-levels.3,6,22 The absence of discrete K-level score ranges warrant further research to determine if functional mobility classification differences exist and can be quantified by currently available outcome measures.3,6

An investigation into functional mobility differences between K-levels may assist clinicians with both selecting appropriate outcome measures for a given client and interpreting results within the context of the current K-level assignment system. This study’s objective was to determine if there are differences in self-report and performance-based function among adults with a lower-limb amputation classified as functional-level K3 versus K4. We hypothesized that K3-classified adults would score lower on self-report questionnaires and the AMPPRO, have slower Timed Up and Go (TUG) times, ambulate at slower speeds, and walk shorter distances during the 6MWT, when compared to those classified as K4.

Methods

Study Sample

Participants were recruited from April 2014 to November 2016 through an interdisciplinary Amputee Clinic at the University of Delaware. Participants were included if they were ≥18 years-old, community-dwelling, and had a unilateral transfemoral or transtibial amputation. Patients with bilateral amputations and/or hip or knee disarticulations were excluded. Additional inclusion criteria included current prosthetic device use, completion of all clinical measures of interest, and K3- or K4-classification, as determined by the evaluating practitioners. Participants signed an informed consent document approved by the Institutional Review Board for Human Subjects at the University of Delaware.

Overview of Procedures

The principal investigator directly supervised all data collections and conducted 1-hour training sessions for staff involved in administration of the standardized clinical evaluations; training sessions reviewed the procedures, patient instructions for physical performance tests, and scoring criteria for the outcome measures. K-level was determined by group consensus of administering clinicians, i.e. a physiatrist, physical therapists, and prosthetists, considering all clinical data collected (Table 1).

Table 1.

Clinical Examination Components Involved in Functional Level Determination

Examination Components
Past Medical and Surgical History Current/Past Problems with Residual Limb
Medical History Checklist
Medication List
Review of Systems (e.g. Respiratory, Cardiovascular, Endocrine)
Social History and Psychosocial Factors Self-reported Motivation to Ambulate
Ambulation and Exercise-Related Goals
Home Environment/Environmental Barriers
Physical Fitness/Recreational Activities
Work Requirements
Coping Self-Efficacy Scale
Community Integration Questionnaire
2-Item Depression Screen
Self-Report Questionnaires Socket Fit Comfort Score
Patient-Specific Functional Scale
General Practice Physical Activity Questionnaire
Activities-specific Balance Confidence Scale
Prosthesis Evaluation Questionnaire – Mobility Section
Locomotor Capabilities Index
Houghton Scale of Prosthetic Use
Cognition and Mental Status Folstein Mini-Mental Status Examination
Constitutional Assessment Pain Diagram/Ratings
Height and Weight (with prosthesis)
Resting and Post-Activity Vital Signs
Lung and Heart Auscultation
Snellen Test for Visual Acuity
Lower Extremity Pulse Assessment
Lower Extremity Edema Assessment
Condition of Residual Limb (i.e. shape, surgical incision/scar, skin integrity)
Musculoskeletal Assessment Manual Muscle Testing of Upper Extremities & Lower Extremities
Joint Range of Motion of Lower Extremities
Knee Joint Effusion
Thomas Test
Neurological Assessment Light Touch and Proprioception Testing
Reflex Testing
Semmes-Weinstein Monofilament Examination
Physical Performance Tests Timed Up and Go
L-Test of Functional Mobility
10 Meter Walk Test
6 Minute Walk Test
Berg Balance Test
Amputee Mobility Predictor

Self-Report Questionnaires

For the Locomotor Capabilities Index (LCI), patients with lower-limb amputations rate their perceived ability on 14 mobility-related items, with a score of 4 indicating ability to complete the task independently without an assistive device.3,16,17 Higher scores indicate greater mobility; the maximum is 56 points.17 This LCI is reliable, valid, and responsive to change.16,17

The Prosthesis Evaluation Questionnaire-Mobility Section (PEQ-MS) assesses functional abilities when using a prosthesis.18,19 Items are ranked from 0 to 4, where 4 indicates the individual has no problem completing or is almost fully able to complete the activity.18 Higher scores indicate better mobility; reliability, validity, and responsiveness have been established.18,19

Performance-Based Tests

The TUG assesses basic mobility components, including comfortable gait speed, dynamic balance, turning, and transfers.3,23 Participants are instructed to stand up from a chair, walk 3 meters, turn 180-degrees, walk back to the chair, and sit down.3,23 The TUG has established reliability and validity in individuals with lower-limb amputations.3,24,25

The 10 Meter Walk Test (10MWT), perhaps the most valid clinical assessment of walking speed, was conducted at self-selected (10MWT-SS) and fast (10MWT-F) speeds.3,26,27 Participants were instructed to “walk” along a straight, 10-meter path, at a “normal, comfortable speed”28 and “as fast and as safely as possible”; speeds were calculated over the middle 6 meters to allow for acceleration and deceleration at either end.3 The 10MWT has established validity in individuals with lower-limb amputations.25

The AMPPRO is a 21-item assessment that evaluate static and dynamic balance, transfers, and gait in adults using a lower-limb prosthesis.6,21 The AMPPRO has established reliability and validity and is correlated to both 6MWT scores and K-level classifications.6,20,21 The maximum score is 47 points.

The 6MWT assesses walking function and endurance. Participants were instructed to cover as much ground as possible while walking quickly but safely along a rectangular path; assistive device use was allowed.3,29 Reliability of the 6MWT has been established in multiple patient populations.3,26,29–31 Among individuals with lower-limb loss, the 6MWT is both reliable and valid, and distance walked has been correlated to K-level classification.3,6,20

Statistical Analysis

Statistical analyses were performed using SPSS Statistics 23 (Armonk, NY). Descriptive analyses were conducted to determine participant demographic characteristics for both functional levels, i.e. K3 and K4. Independent t-tests (or Pearson Chi Square tests) evaluated for between-group differences, after checking to ensure that continuous data met parametric assumptions. Multivariate analysis of covariance was used to test between-group differences for outcome measures, while controlling for age, body mass index (BMI), time since amputation, and cause of amputation (p≤0.050). Follow-up analyses of covariance (ANCOVA) were used to explore between-group differences (p≤0.050). Effect sizes were calculated. Assumptions for parametric testing were evaluated; Brown-Forsythe and Welch tests for equality of means were performed when homogeneity of variance was not met to ensure that assumptions were not violated.

Results

Study Size & Participants

In total, 137 participants were considered for study inclusion (Figure 1). Ninety-nine were currently using a prosthesis, of which, 76 were classified as K3- or K4-level. Of these 76, 69 had a unilateral transfemoral or transtibial amputation. Of the 69 participants, 35 and 20 participants classified as K3 and K4, respectively, completed all measures of interest. Participant demographics are provided in Table 2. Individuals classified as K3 were older (p<.001), had higher BMIs (p=.009), and had less time elapsed since their amputation (p=.035). Cause of amputation also differed between groups (χ2=12.788, p=.023, Figure 2).

Figure 1. Sample Delineation Based on Exclusion and Inclusion Criteria.

Figure 1

Abbreviations: BMI = Body Mass Index; PEQ-MS = Prosthetic Evaluation Questionnaire-Mobility Section; LCI = Locomotor Capabilities Index; 10MWT = 10 Meter Walk Test; 6MWT = 6 Minute Walk Test.

Table 2.

Patient Demographics

K3 (n=35) K4 (n=20) p-value
Mean ± SD (95% CI)
Sex (Male)* 28 (80%) 13 (65%) .219
Race (Caucasian)* 27 (77%) 12 (60%) .122
Ethnicity (Non-Hispanic)* 33 (94%) 15 (75%) .072
Amputation Type (Transtibial)* 24 (69%) 10 (50%) .173
Age (years) 60 ± 12 (56–64) 46 ± 12 (41–51) <.001
Height (m) 1.76 ± .31 (1.72–1.78) 1.74 ± .10 (1.69–1.78) .451
Weight (kg)† 92.9 ± 20.1 (86.3–99.5) 79.0 ± 20.8 (70.8–88.3) .102
BMI (kg/m2)** 29.8 ± 5.0 (28.2–31.6) 26.0 ± 5.1 (23.9–28.3) .009
Time Since Amputation (years) 11 ± 14 (7–17) 21 ± 15 (13–27) .035
Residual Limb Pain Rating‡ 2 ± 3 (1–3) 2 ± 3 (0–3) .644
*

Represented as n (% of sample) rather than Mean ± SD (95% CI)

†

Weight and BMI measurements included prosthesis.

‡

Pain ratings scored on a Numeric Pain Rating Scale from 0–10 (0=no pain, 10=worst pain imaginable)

Abbreviations: m=meters; kg=kilograms; BMI = body mass index; kg/m2= kilograms per meter squared.

p≤.050

Figure 2. Cause of Amputation Among Patients Included in Analyses.

Figure 2

A higher proportion of individuals classified as K3 reported diabetes (DM) and peripheral vascular disease (PVD) as the primary cause of amputation compared to those classified as K4 (χ2=12.788, p=.023).

Difference in Outcome Measures Between Groups

Controlling for covariates, self-reported functional mobility did not differ significantly between K3- and K4-levels; overlapping 95% CIs were found (Table 3). ANCOVAs revealed significant differences in TUG times, 10MWT speeds, AMPPRO scores, and 6MWT distances (Table 3). TUG times were significantly greater in those classified as K3-level, representing poorer functional mobility (p=.002). For 10MWT, participants classified as K3-level walked slower at both self-selected (p<.001) and fast (p<.001) speeds. AMPPRO scores for participants classified as K3-level, i.e. 40.4 points, were lower than those classified as K4, i.e. 44.9 (p<.001). Finally, for 6MWT, K3-classified participants walked shorter distances than K4-classified participants (p=.003). For all physical performance measures, 95% CIs did not overlap between groups.

Table 3.

Between-Group in Self-Report Questionnaires and Physical Performance Tests*

K3 (n=35) K4 (n=20) Partial Eta Squared p-value
Adjusted Mean ± SE (95% CI)
LCI 49.1 ± 1.6 (45.8–52.3) 48.8 ± 2.3 (44.2–53.4) .000 .934
PEQ-MS 3.05 ± .16 (2.73, 3.37) 3.11 ± .22 (2.66, 3.57) .001 .842
TUG (s) 12.82 ± .54 (11.74–13.89) 9.45 ± .76 (7.92–10.98) .195 .002
10MWT-SS (m/s) .88 ± .04 (.80–.96) 1.21 ± .05 (1.11–1.32) .326 <.001
10MWT-F (m/s) 1.12 ± .05 (1.02–1.22) 1.56 ± .07 (1.41–1.70) .309 <.001
AMPPRO (points) 40.4 ± 0.4 (39.6–41.2) 44.9 ± 0.6 (43.7–46.0) .429 <.001
6MWT (m) 311.30 ± 18.98 (273.05–349.55) 427.42 ± 26.94 (373.13–481.70) .186 .003
*

Adjusted for covariates (age, BMI, time since amputation, and reason for amputation)

Abbreviations: SE = standard error; s = seconds; m = meters.

p<.050

Discussion

Significant between-group differences were found for selected performance-based tests and confirmed our hypotheses that adults with a unilateral transfemoral or transtibial amputation classified as K3-level have worse functional mobility, walk at distinctly slower gait speeds, have lower AMPPRO scores, and walk shorter distances during extended walking bouts. Statistically-significant differences and non-overlapping 95% CIs between K3 and K4-classified groups suggest that the TUG and 10MWT distinguish between functional levels in adults with a unilateral amputation. Thus, these measures may be used alongside the AMPPRO and 6MWT during clinical evaluations for community-dwelling adults with a unilateral transfemoral or transtibial amputation to aid in objective assignment of K-level. Conversely, the LCI and PEQ-MS, two self-report questionnaires, did not delineate between K3 and K4 functional mobility in this patient sample.

Multidimensional sets of outcome measures have been shown to more accurately assess functional mobility when compared to using a single measure in various patient populations.32–35 While our results suggest that each performance-based test may independently differentiate between K3- and K4-levels, use of a collection of tests, where different tests evaluate various aspects of functional mobility, allows clinicians to comprehensively assess mobility potential. Further, clinical decisions should rarely be based on the results of a single test, but rather on the synthesis of information obtained from multiple sources. Thus, the use of a battery of psychometrically-sound, performance-based tests that comprehensively assess functional mobility may enhance K-level classification objectivity and accuracy for adults with unilateral lower-limb loss. This study provides foundational knowledge for determining a collection of outcome measures that may predict mobility status for higher-functioning adults with a unilateral lower-limb amputation. Results suggests that the TUG, 10MWT, AMPPRO, and 6MWT have promise and warrant further research through a longitudinal, prospective study.

TUG times found in this study were faster than previously published. Miller et al. reported average TUG times (±standard devation (SD)) of 19.4±15.5 seconds in adults with unilateral transtibial and transfemoral amputations,36 while Schoppen et al. reported 23.1±23.0 and 28.3±12.2 seconds in older adults with unilateral transtibial and transfemoral amputations, respectively.24 Discrepancies between our data and abovementioned studies may be attributed to differences in sample characteristics; specifically, our sample included participants with greater time elapsed since amputation compared to those in the abovementioned studies with postoperative means of 3.4 years36 and 7.1±3.4 years.24 While all samples included long-term prosthetic users,24,36 greater time since amputation may explain better functional mobility in our sample. Both Miller et al. and Shoppen et al. included participants classified as K2 or below,24,36 which may also explain worse functional mobility results. As our sample was younger than the Schoppen et al. sample,24 age may also help to explain differences. Overall, findings suggest subgrouping (e.g. by time elapsed since amputation, functional mobility level, and age) or at a minimum, controlling for covariates, is needed when providing clinicians with data to assist with functional classification.

Independent of age, BMI, amputation etiology, and time since amputation, 10MWT results demonstrate that individuals classified as K3 versus K4, walked slower at both self-selected and fast speeds. Reference norms for 10MWT gait speeds for adults with lower-limb loss do not exist.37 Self-selected walking speed of our K3-classified participants, i.e. .88 (95% CI: .80–.96) m/s, however, was within the range previously reported for K3-classified adults.6,38 Our mean self-selected speed of 1.21 (95% CI: 1.11–1.32) in K4-classified adults was also similar to mean speeds (±SD), i.e. 1.17±.24 m/s, reported in a similar sample.6 In young, military personnel post-unilateral traumatic amputations, self-selected walking speeds of 1.3 m/s (range 1.2–1.6 m/s)39 and 1.12 (SD: .11 m/s)40 have been reported at 108.6±67.2 and 50.3±54.1 months post-amputation, respectively.39,40 Among older adults with dysvascular amputations following 13.7±16.8 weeks of prosthetic training, mean speeds (±SD) of .88±.39 m/s are reported.41 Large differences in self-selected gait speeds among various limb loss populations suggest multiple variables for consideration in development of reference gait speeds including functional mobility status, age, physical activity level, amputation etiology, and time elapsed since the amputation.

There were significant differences in sample characteristics, specifically age and BMI, between our K3 and K4 participants. While both were covariates during data analyses, these factors may impact K-level. For example, aging may limit participation in high-level activities given the increased prevalence of comorbidities and physical inactivity.42 Advanced age has been associated with decreased balance-confidence among adults with lower-limb amputations.43 Furthermore, while research has shown that increased BMI is not correlated to decreased function,44 high BMI is linked to orthopedic and cardiovascular pathologies, heightening the metabolic and structural demands of mobility tasks and possibly explaining why participants with higher BMIs were more likely to be K3-classified in our study.45

The 6MWT and AMPPRO have demonstrated score differences in adults with varying K-levels.6,15 Gailey et al. reported mean (±SD) 6MWT distances of 299±102m (range: 48–475) and 419±86m (range: 264–624) for adults classified as K3 and K4, respectively.6 We found similar mean 6MWT distances of 311m (95% CI: 273–349) versus 427m (95% CI: 373–481) in K3- versus K4-classified individuals. Gailey et al. reported mean (±SD) AMPPRO scores of 40.5±3.9 (range: 26–46) and 44.7±1.8 (range: 38–47) points for individuals classified as K3 and K4, respectively.6 Hafner and colleagues more recently reported mean(±SD) AMPPRO scores of 40.4±4.3 (range: 28–47) for K3- and 44.6±1.9 (39–47) for K4-classified adults with a major, unilateral lower-limb amputation.15 Our AMPPRO scores were similar at 40.4 (95% CI: 39.6–41.2) and 44.9 (95% CI: 43.7–46.0) for K3- and K4-classified patients, respectively. Further, our 6MWT and AMPPRO data, based on distinct 95% CIs for each group, suggest clear differences in physical performance between K3- and K4-classified patients with a unilateral transfemoral or transtibial amputation and may be used to help practitioners classify similar patients.

Overlapping ranges between classification levels in the prior studies by Gailey et al. and Hafner et al. may be attributed to heterogeneous samples, including participants with amputations of varying levels (ankle to hip)6,15 and/or inclusion of patients with sound side amputations (e.g. partial foot amputations).6 To further illustrate the issue with heterogeneous samples, consider the study by Reid et al. evaluating ambulation distance during 2- and 6MWTs among adults with unilateral and bilateral amputations of various amputation levels.46 While the tests were able to differentiate among lower-functioning, i.e. K1 and K2, versus higher-functioning, i.e. K3 and K4, these tests were unable to discriminate between K3 versus K4 levels.46

In our study, supervised data collections were conducted at a single clinic, rather than at multiple sites. As research has demonstrated inter-clinician variability in observation-based functional assessment of adults with limb loss,47 K-level assignment was determined by group consensus of an interdisciplinary team comprised of the evaluating physiatrist and at least 1 of 2 licensed physical therapists, and 1 of 3 certified prosthetists. Given outcome measure score ranges were similar to previous studies,6,15 using group consensus may have resulted in greater K-level assignment accuracy,6,21,48,49 although reliability was not specifically evaluated. Akin to clinical practice, when assigning K-level, practitioners were not blinded to the results of outcome measures evaluated. An acknowledged trade-off of employing a clinical classification approach for this study is potential overestimation of the ability of the selected measures to differentiate between K-levels. Other researchers have utilized medical records to obtain functional level classification, had site practitioners from multiple sites administer the outcome measures, and assessed for differences in outcome measures based on classification level.15 Such methods exert less control over variables considered in K-level assignment, i.e. practitioners may have access to and factor into K-level classification different data than their peers based on availability of data in the medical chart. The use of multiple sites and practitioners may also increase variability in outcome measure administration.

High LCI and PEQ-MS scores were reported for both K3- and K4-groups, aligning historically with research suggesting measurement ceiling effects.17–19,50,51 Our results support the premise that items referenced in both questionnaires may be considered low-level by higher-functioning adults, rendering these surveys incapable of capturing self-perceived mobility exceeding basic ambulation.18,19,50,51 Development and validation of self-report measures for adults with lower-limb loss incorporating more challenging activities are ongoing.15 And it is possible, that with increased sample sizes, small between-group differences in self-report questionnaires may be discovered. For example, recently Hafner et al. demonstrated significant differences in PEQ-MS scores between K3- and K4-classified adults; means (±SD) for K3-classified patients were 2.4±0.8 and K4-classified patients were 2.8±0.6.15

Study Limitations

Study strengths included use of a standardized clinical evaluation, mandatory examiner training, and administration of self-report questionnaires prior to performance tests, minimizing the influence of patient performance on self-reported function. This study, however, used a clinical dataset, limiting sample size to eligible participants who completed all measures of interest. Given sample size, we did not stratify by other covariates that may impact functional mobility.39,40 While a covariate, BMI was calculated from weight with the prosthetic and without amputation level consideration. Furthermore, participants may not have performed at their actual physical potential during clinical testing,52 and failure to blind practitioners may have resulted in overestimation of the measures to differentiate between K-levels.

Generalizability of results is limited to community-dwelling patients with unilateral amputations who are longer-term prosthesis-users. Adults with bilateral amputations likely have worse functional mobility;39,53 we cannot advocate the use of this data for classifying such patients, nor patients early post-amputation. While our participants largely reflect populations with limb loss, the majority of our sample were males with unilateral transtibial amputations.1,22,54

Conclusions

Prosthetic prescription for adults with lower-limb amputations is based on functional mobility status, necessitating the use of reliable and valid measures that differentiate between K- level classifications. Outcome measure use in determining K-level is advantageous as it decreases reliance on clinicians’ subjective interpretations of patient mobility. Study findings align with the majority of research suggesting the LCI and PEQ-MS may not differentiate between K3- and K4-functional levels. Practitioners may use the 95% CIs provided in this dataset to help interpret TUG times, 10MWT gait speeds, AMPPRO scores, and 6MWT distances and distinguish between K3- and K4-functional levels in community-dwelling patients with a unilateral transfemoral or transtibial amputation who are longer-term prosthetic users. Future studies utilizing practitioners blinded to the physical performance measures utilized to determine K-level may strengthen this study’s findings.

Highlights.

  • Patients with limb loss were classified by an interdisciplinary healthcare team.

  • K3-classified patients had worse physical performance than K4-classified peers.

  • Self-reported physical function was similar between K3- and K4-classified patients.

Acknowledgments

Funding: This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors. However, data analysis and manuscript preparation was provided, in part, by the National Institute of Health grant 5T32HD007490-17.

The authors wish to thank the participants of this study, as well as the personnel who assisted with data collections during the University of Delaware Amputee Clinic.

Abbreviations

AMPPRO

Amputee Mobility Predictor

ANCOVA

Analyses of Covariance

BMI

Body Mass Index

CI

Confidence Interval

LCI

Locomotor Capabilities Index

m/s

Meters per Second 95%

CI

95% Confidence Interval

PEQ-MS

Prosthesis Evaluation Questionnaire-Mobility

Section TUG

Timed Up and Go

6MWT

6 Minute Walk Test

SD

Standard Deviation

10MWT

10 Meter Walk Test

10MWT-SS

10 Meter Walk Test-Self Selected Speed

10MWT-F

10 Meter Walk Test-Fast Speed

Footnotes

Presentation: This data was presented, in part, at the AOPA National Assembly in Boston, MA on 9/10/2016, as a platform presentation entitled: Differences in Physical Performance Measures among Patients with Unilateral Limb Amputations Classified as Functional Level K3 versus K4.

Conflicts of interest: Dr. Sions is a consultant for Independence Prosthetics-Orthotics, Inc.

Reprints are not available for this manuscript.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Ziegler-Graham K, MacKenzie EJ, Ephraim PL. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil. 2008;89:622–629. doi: 10.1016/j.apmr.2007.11.005. [DOI] [PubMed] [Google Scholar]
  • 2.Humphries MD, Brunson A, Chin-Shang L, et al. Amputation trends for patients with lower extremity ulcers due to diabetes and peripheral artery disease using statewide data. J Vasc Surg. 2016;64:1747–1755. doi: 10.1016/j.jvs.2016.06.096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Stevens P, Fross N, Kapp S. Clinically relevant outcome measures in orthotics and prosthetics. The Academy Today. 2009:5A4–11. [Google Scholar]
  • 4.Webster JB, Hakimi KN, William RM, et al. Prosthetic fitting, use, and satisfaction following lower-limb amputation: a prospective study. J Rehabil Res Dev. 2012;49:1493–1506. doi: 10.1682/jrrd.2012.01.0001. [DOI] [PubMed] [Google Scholar]
  • 5.Schaffalitzky E, Gallagher P, Maclachlan M, Ryall N. Understanding the benefits of prosthetic prescription: exploring the experiences of practitioners and lower limb prosthetic users. Disabil Rehabil. 2011;33:1314–1323. doi: 10.3109/09638288.2010.529234. [DOI] [PubMed] [Google Scholar]
  • 6.Gailey RS, Roach KE, Applegate EB, Cho B, Cunniffe B, Licht S, Maguire M, Nash MS. The amputee mobility predictor: an instrument to assess determinants of the lower-limb amputee’s ability to ambulate. Arch Phys Med Rehabil. 2002;83:613–627. doi: 10.1053/apmr.2002.32309. [DOI] [PubMed] [Google Scholar]
  • 7.Kaluf B. Evaluation of Mobility in Persons with Limb Loss Using the Amputee Mobility Predictor and the Prosthesis Evaluation Questionnaire mobility subscale: a six-month retrospective chart review. J Prosthet Orthot. 2014;26:70–76. [Google Scholar]
  • 8.Kurichi JE, Kwong PL, Reker DM, et al. Clinical factors associated with prescription of a prosthetic limb in elderly veterans. J Am Geriatr Soc. 2007;55:900–906. doi: 10.1111/j.1532-5415.2007.01187.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Fleury AM, Salih SA. Rehabilitation of the older vascular amputee: A review of the literature. Geriatr Gerontol Int. 2013;13:264–73. doi: 10.1111/ggi.12016. [DOI] [PubMed] [Google Scholar]
  • 10.HCFA Common Procedure Coding System HCPCS 2001. ch 5.3 Washington (DC): US Government Printing Office; 2001. [Google Scholar]
  • 11.Borrenpohl, et al. Survey of US practitioners on the validity of the Medicare functional classification level system and utility of clinical outcome measures for aiding K-level assignment. Arch Phys Med Rehabil. 2016;97:1053–63. doi: 10.1016/j.apmr.2016.02.024. [DOI] [PubMed] [Google Scholar]
  • 12.Gaunard I, Spaulding SE, Amtmann D, et al. Use of and confidence in administering outcome measures among clinical prosthetists: Results from a national survey and mixed-methods training program. Prosthet Orthot Int. 2015;39:314–321. doi: 10.1177/0309364614532865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Centers for Medicare and Medicaid Services. [Accessed April 10, 2017];Implementing the claims-based data collection requirement for outpatient therapy services – section 3005(g) of the Middle Class Tax Relief and Job Creation Act (MCTRJCA) of 2012. Published 2012. Available at: http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/Downloads/MM8005.pdf.
  • 14.Reiman MP, Manske RC. The assessment of function: how is it measured? A clinical perspective. J Man Manip Ther. 2011;19:91–99. doi: 10.1179/106698111X12973307659546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hafner BJ, Gaunaurd IA, Morgan SJ, Amtmann D, Salem R, Gailey RS. Construct Validity of the Prosthetic Limb Users Survey of Mobility (PLUS-M) Arch Phys Med Rehabil. 2017;98:277–285. doi: 10.1016/j.apmr.2016.07.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Heinemann AW, Connelly L, Ehrlich-Jones L, Fatone S. Outcome instruments for prosthetics. Phys Med Rehabil Clin N Am. 2014;25:179–198. doi: 10.1016/j.pmr.2013.09.002. [DOI] [PubMed] [Google Scholar]
  • 17.Franchignoni F, Orlandini D, Ferriero Gi, Moscato T. Reliability, validity, and responsiveness of the locomotor capabilities index in adults with lower-limb amputation undergoing prosthetic training. Arch Phys Med Rehabil. 2006;85:743–8. doi: 10.1016/j.apmr.2003.06.010. [DOI] [PubMed] [Google Scholar]
  • 18.Franchignoni F, Giordano A, Orlandini D, et al. Measuring mobility in people with lower limb amputation: Rasch analysis of the mobility section of the prosthesis evaluation questionnaire. J Rehabil Med. 2007;39:138–44. doi: 10.2340/16501977-0033. [DOI] [PubMed] [Google Scholar]
  • 19.Miller WC, Deathe B, Speechley M. Lower extremity prosthetic mobility: a comparison of 3 self-report scales. Arch Phys Med Rehabil. 2001;82:1432–1440. doi: 10.1053/apmr.2001.25987. [DOI] [PubMed] [Google Scholar]
  • 20.Resnik L, Brogia M. Reliability of outcome measures for people with lower-limb amputations: distinguishing true change from statistical error. Phys Ther. 2011;91:555–65. doi: 10.2522/ptj.20100287. [DOI] [PubMed] [Google Scholar]
  • 21.Gailey RS. Predictive outcome measures versus functional outcome measures in the lower limb amputee. J Prosthet Orthot. 2006;18:51–60. [Google Scholar]
  • 22.Kannenberg A, Zacharias B, Pröbsting E. Benefits of microprocessor-controlled prosthetic knees to limited community ambulators: systematic review. J Rehabil Res Dev. 2014;51:1469–96. doi: 10.1682/JRRD.2014.05.0118. [DOI] [PubMed] [Google Scholar]
  • 23.Podsiadlo D, Richardson S. The timed “up and go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142–8. doi: 10.1111/j.1532-5415.1991.tb01616.x. [DOI] [PubMed] [Google Scholar]
  • 24.Schoppen T, Boonstra A, Groothoff JW, et al. The timed “up and go” test: reliability and validity in persons with unilateral lower limb amputations. Arch Phys Med Rehabil. 1999;80:825–828. doi: 10.1016/s0003-9993(99)90234-4. [DOI] [PubMed] [Google Scholar]
  • 25.Deathe AB, Miller WC. The L test of functional mobility: measurement properties of a modified version of the timed “up & go” test designed for people with lower-limb amputations. Phys Ther. 2005;8:626–35. [PubMed] [Google Scholar]
  • 26.Scivoletto G, Tamburella F, Laurenza L, et al. Validity and reliability of the 10-m walk test and the 6-min walk test in spinal cord injury patients. Spinal Cord. 2011;49:736–740. doi: 10.1038/sc.2010.180. [DOI] [PubMed] [Google Scholar]
  • 27.Roffman CE, Buchanan J, Allison GT. Locomotor performance during rehabilitation of people with lower limb amputation and prosthetic nonuse 12 months after discharge. Phys Ther. 2016;96:985–94. doi: 10.2522/ptj.20140164. [DOI] [PubMed] [Google Scholar]
  • 28.Bohannon RW. Comfortable and maximum walking speed of adults aged 20–79 years: reference values and determinants. Age Ageing. 1997;26:15–9. doi: 10.1093/ageing/26.1.15. [DOI] [PubMed] [Google Scholar]
  • 29.Rikli R, Jones C. The reliability and validity of a 6-minute walk test as a measure of physical endurance in older adults. J Aging Phys Act. 1998;6:363–375. [Google Scholar]
  • 30.Bellet, et al. Repeated six-minute walk tests for outcome measurement and exercise prescription in outpatient cardiac rehabilitation: a longitudinal study. Arch Phys Med Rehabil. 2011;92:1388–94. doi: 10.1016/j.apmr.2011.04.014. [DOI] [PubMed] [Google Scholar]
  • 31.Jenkins SC. 6-Minute walk test in patients with COPD: clinical applications in pulmonary rehabilitation. Physiotherapy. 2007;93:175–182. [Google Scholar]
  • 32.Geyh S, Cieza A, Schouten J, et al. ICF core sets for stroke. J Rehabil Med. 2004:135–141. doi: 10.1080/16501960410016776. [DOI] [PubMed] [Google Scholar]
  • 33.Dobson F, Hinman RS, Roos EM, et al. OARSI recommended performance-based tests to assess physical function in people diagnosed with hip or knee osteoarthritis. Osteoarthritis Cartilage. 2013;21:1042–1052. doi: 10.1016/j.joca.2013.05.002. [DOI] [PubMed] [Google Scholar]
  • 34.Marino RJ, Graves DE. Metric properties of the ASIA motor score: subscales improve correlation with functional activities. Arch Phys Med Rehabil. 2004;85:1804–10. doi: 10.1016/j.apmr.2004.04.026. [DOI] [PubMed] [Google Scholar]
  • 35.Sibley KM, Howe T, Lamb SE, et al. Recommendations for a Core Outcome Set for Measuring Standing Balance in Adult Populations: A Consensus-Based Approach. PLoS One. 2015;10(3):e0120568. doi: 10.1371/journal.pone.0120568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Miller WC, Deathe AB, Speechley M. Psychometric properties of the Activities-specific Balance Confidence scale among individuals with a lower-limb amputation. Arch Phys Med Rehabil. 2003;84:656–661. doi: 10.1016/s0003-9993(02)04807-4. [DOI] [PubMed] [Google Scholar]
  • 37.Deathe AB, Wolfe DL, Devlin M, et al. Selection of outcome measures in lower extremity amputation rehabilitation: ICF activities. Disabil Rehabil. 2009;31:1455–1473. doi: 10.1080/09638280802639491. [DOI] [PubMed] [Google Scholar]
  • 38.Wong CK, Gibbs W, Chen E. Use of the Houghton Scale to classify community and household walking ability in people with lower limb amputation: criterion-related validity. Arch Phys Med Rehabil. 2016;97:1130–1136. doi: 10.1016/j.apmr.2016.01.022. [DOI] [PubMed] [Google Scholar]
  • 39.Akarsu S, Tekin L, Safaz I, et al. Quality of life and functionality after lower-limb amputations: comparison between uni-vs. bilateral amputee patients. Prosthet Orthot Int. 2013;37:9–13. doi: 10.1177/0309364612438795. [DOI] [PubMed] [Google Scholar]
  • 40.Tekin L, Safaz Y, Göktepe AS. Comparison of quality of life and functionality in patients with traumatic unilateral below knee amputation and salvage surgery. Prosthet Orthot Int. 2009;33:17–24. doi: 10.1080/03093640802482542. [DOI] [PubMed] [Google Scholar]
  • 41.Christiansen CL, Fields T, Lev G, et al. Functional outcomes after the prosthetic training phase of rehabilitation after dysvascular lower extremity amputation. PM R. 2015;7:1118–1126. doi: 10.1016/j.pmrj.2015.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Guthold R, Ono T, Strong KL, Chatterji S, Morabia A. Worldwide variability in physical activity. Am J Prev Med. 2008;34:486–494. doi: 10.1016/j.amepre.2008.02.013. [DOI] [PubMed] [Google Scholar]
  • 43.Miller WC, Speechley M, Deathe AB. Balance confidence among people with lower-limb amputations. Phys Ther. 2002;82:856–865. [PubMed] [Google Scholar]
  • 44.Vivas LL, Pauley T, Dilkas S, Devlin M. Does size matter? Examining the effect of obesity on inpatient amputation rehabilitation outcomes. Disabil Rehabil. 2017;39:36–42. doi: 10.3109/09638288.2016.1140831. [DOI] [PubMed] [Google Scholar]
  • 45.Kahle JT, Highsmith MJ. Motion. Amputee Coalition; 2008. [Accessed on 7/28/18]. The implications of amputees being overweight; p. 18. http://www.amputee-coalition.org/resources/the-implications-of-amputees/ [Google Scholar]
  • 46.Reid L, Thomson P, Besemann M, Dudek N. Going places: does the two-minute walk test predict the six-minute walk test in lower extremity amputees? J Rehabil Med. 2015;47:256–261. doi: 10.2340/16501977-1916. [DOI] [PubMed] [Google Scholar]
  • 47.Sansam K, O’Connor RJ, Neumann V, Bhakta B. Clinicians’ perspectives on decision making in lower limb amputee rehabilitation. J Rehabil Med. 2014;46:447–453. doi: 10.2340/16501977-1791. [DOI] [PubMed] [Google Scholar]
  • 48.Pomeranz B, Adler U, Shenoy N, Macaluso C, Parikh S. Prosthetics and orthotics for the older adult with a physical disability. Clin Geriatr Med. 2006;22:377–94. doi: 10.1016/j.cger.2005.12.006. [DOI] [PubMed] [Google Scholar]
  • 49.Spruit-van Eijk M, van der Linde H, Buijck B, Geurts A, Zuidema S, Koopmans R. Predicting prosthetic use in elderly patients after major lower limb amputation. Prosthet Orthot Int. 2012;36:45–52. doi: 10.1177/0309364611430885. [DOI] [PubMed] [Google Scholar]
  • 50.Salavati M, Mazaheri M, Khosrozadeh F, Mousavi SM, Negahban H, Shojaei H. The Persian version of locomotor capabilities index: translation, reliability and validity in individuals with lower limb amputation. Qual Life Res. 2011;20:1–7. doi: 10.1007/s11136-010-9716-3. [DOI] [PubMed] [Google Scholar]
  • 51.Larsson B, Johannesson A, Andersson IH, Atroshi I. The Locomotor Capabilities Index: validity and reliability of the Swedish version in adults with lower limb amputation. Health Qual Life Outcomes. 2009;7:66. doi: 10.1186/1477-7525-7-44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Studenski S, Perera S, Wallace D, et al. Physical Performance Measures in the Clinical Setting. J Am Geriatr Soc. 2003;51:314–322. doi: 10.1046/j.1532-5415.2003.51104.x. [DOI] [PubMed] [Google Scholar]
  • 53.Raya MA, Gailey R, Gaunaurd IA, et al. Amputee Mobility Predictor-Bilateral: A performance-based measure of mobility for people with bilateral lower-limb loss. J Rehabil Res Dev. 2013;50:961–8. doi: 10.1682/JRRD.2012.05.0097. [DOI] [PubMed] [Google Scholar]
  • 54.Amtmann D, Morgan SJ, Kim J, Hafner BJ. Health-related profiles of people with lower limb loss. Arch Phys Med Rehabil. 2015;96:1474–83. doi: 10.1016/j.apmr.2015.03.024. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES